Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02EVT
|
||||
Former ID |
DIB001029
|
||||
Drug Name |
SAR-152954
|
||||
Synonyms |
Histamine H3 antagonist (sleep disorder), Sanofi-aventis
|
||||
Indication | Sleep disorders [ICD9: 307.4, 327, 780.5; ICD10:F51, G47] | Discontinued in Phase 1 | [1] | ||
Company |
Sanofi
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Histamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Monoamine Transport | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033674) | ||||
REF 2 | Clinical pipeline report, company report or official report of Sanofi. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.